*** NEW AWARD*** 

 My book ETHICAL CHIC: The Inside Story of the Companies We Think We Love

has just been named one of the Best Business Books of 2012 by Library Journal


This book analyzes six well-known companies that are seen as socially responsible and hip, to see if they really deserve their sterling reputations.

Find out the real story about Starbucks, Apple, Trader Joe’s, American Apparel, Tom’s of Maine and Timberland:.


I am a prize-winning author and journalist with over 20 years of experience specializing in health care, retirement issues, and the nexus between business and public policy. I write regularly for The New York Times, Newsday, The Scientist, Institutional Investor, and more

For the FDA, Ebola Should Be the Next AIDS

The New York Times, Aug. 17, 2014


The horrific spread and high fatality rates of Ebola seem to be outrunning the capabilities of modern medicine and communication, while the lack of effective medicines has raised tough ethical choices about who should get scarce dosages. (African and Western doctors, yes. Elderly Western priests, no.)But the path of the FDA should be more clear. Yes, the FDA needs to take every precaution in assuring safety with normal drugs that treat debilitating, painful, chronic, or even frivolous conditions. But Ebola is like lung cancer or AIDS ten times over: Do we really care about the side effects — or even the effectiveness — in the case of a fatal disease with no known treatment? The FDA needs to become proactive, work with the CDC in identifying potential new pathogens early, and speed up its review process in those rare cases.



From the other side: Check out my book reviews for The National at http://www.thenational.ae/featured-content/search?searchKey=Fran+Hawthorne&choice=true&pageNumber=1 and The New York Journal of Books at http://www.nyjournalofbooks.com/search/apachesolr_search/Fran%20Hawthorne

Comments are closed.


Get every new post delivered to your Inbox.

%d bloggers like this: